Stone Point Wealth LLC Gilead Sciences, Inc. Transaction History

Stone Point Wealth LLC

$291 Million
Q1 2025

A detailed history of Stone Point Wealth LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stone Point Wealth LLC holds 32,348 shares of GILD stock, worth $3.33 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

32,348

Previous 30,503 6.05%

Holding current value

$3.33 Million

Previous $2.82 Million 28.65%

% of portfolio

1.25%

Previous 0.96%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$89.14 - $117.41 $164,463 - $216,621	1,845 Added 6.05%	32,348 $3.62 Million
Q4 2024 Jan 28, 2025	BUY	$83.95 - $97.9 $150,942 - $176,024	1,798 Added 6.26%	30,503 $2.82 Million
Q3 2024 Oct 31, 2024	BUY	$66.59 - $83.99 $32,429 - $40,903	487 Added 1.73%	28,705 $2.41 Million
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $458,090 - $528,671	-7,254 Reduced 20.45%	28,218 $1.94 Million
Q1 2024 May 01, 2024	BUY	$71.58 - $87.29 $86,898 - $105,970	1,214 Added 3.54%	35,472 $2.6 Million
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $169,400 - $192,104	-2,312 Reduced 6.32%	34,258 $2.78 Million
Q3 2023 Oct 25, 2023	BUY	$73.94 - $80.67 $201,264 - $219,583	2,722 Added 8.04%	36,570 $2.74 Million
Q2 2023 Jul 25, 2023	BUY	$76.01 - $86.7 $97,140 - $110,802	1,278 Added 3.92%	33,848 $2.61 Million
Q1 2023 Apr 20, 2023	BUY	$77.31 - $88.08 $537,304 - $612,156	6,950 Added 27.13%	32,570 $2.7 Million
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $148,633 - $213,385	2,385 Added 10.26%	25,620 $0
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $87,821 - $100,314	1,475 Added 6.78%	23,235 $1.43 Million
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $22,049 - $24,833	-382 Reduced 1.73%	21,760 $1.35 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $400,053 - $501,310	6,907 Added 45.34%	22,142 $1.32 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $988,446 - $1.12 Million	15,235 New	15,235 $1.11 Million

Others Institutions Holding GILD

# of Institutions

2,189

Shares Held

990M

Call Options Held

8.69M

Put Options Held

9.39M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $129B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Point Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Point Wealth LLC with notifications on news.

Account

Stone Point Wealth LLC Gilead Sciences, Inc. Transaction History